Hearing Aid Versus Surgical Rehabilitation as Treatment of Otosclerosis: Pilot Study
PARCO
2 other identifiers
interventional
30
1 country
1
Brief Summary
This is a French pilot study in the Toulouse University Hospital that will include a minimum of 30 patients with proven unilateral or asymmetric otosclerosis. Each one will receive a hearing aid for a minimum of 2 months and then undergo otosclerosis surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 26, 2015
CompletedFirst Posted
Study publicly available on registry
May 28, 2015
CompletedStudy Start
First participant enrolled
September 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedDecember 10, 2025
May 1, 2018
2.3 years
May 26, 2015
December 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evolution of the quality of life (scored by GHSI)
The primary outcome is to describe the evolution of the quality of life (scored by the Glasgow Health Status Inventory (GHSI)) during the hearing rehabilitation of otosclerosis frst with an external monaural hearing aid (support for at least 2 months), followed by a surgical treatment.
4th Month
Secondary Outcomes (3)
Evolution of the quality of life (scored by SSQ)
Change and evolution at different time points: baseline, 2-month intervention, 2-month after surgery
Evolution of the quality of life (scored by APHAB)
Change and evolution at different time points: baseline, 2-month intervention, 2-month after surgery
Evolution of the quality of life (scored by GBI)
Change and evolution at different time points: baseline, 2-month intervention, 2-month after surgery
Study Arms (1)
External hearing aid & Otosclerosis surgery
EXPERIMENTALTrying an hearing aid for at least two months and then undergo otosclerosis surgery
Interventions
The external hearing aid (monaural) with an auditory prosthesis contour type, brand PHONAK type Bolero Q70 will be provided to the patients during a minimum of 2 months.For reasons of standardization and comparability of results, only one type of prosthesis (medium-high range) will be provided. The settings will be performed by audiologists of ENT service during the inclusion visit.
Surgical restoration of the columellar effect consists of the intraoperative verification of the stapedo-vestibular ankylosis which provides diagnostic. Then a stapedotomy (laser or Ototool°) is performed and partial ossicular prosthesis s inserted between stapedotomy and the long process of the incus.
Eligibility Criteria
You may qualify if:
- Nosological criteria:
- Unilateral or bilateral asymmetric otosclerosis
- Conductive hearing loss of at least 30 dB with an average loss Rinne means greater than or equal to 20 dB (on frequencies 0.5, 1, 2, 4 kHz)
- Normal tympanum
- Temporal bones CT-scan showing radiologic signs of otosclerosis
- Related to treatment criteria:
- No previous treatment for the otosclerosis
You may not qualify if:
- Disease's related criteria:
- Far advanced otosclerosis defined as less than 95dB air conduction at all frequencies or lower bone conduction 55dB on at least one frequency
- Cochlear otosclerosis objectified on the temporal bones Ct-scan
- Others clinical or radiological diagnostics: cholesteatoma, tympanic membrane perforation, geyser's syndrome, ossicular dislocation, ossicular malformation, tympanosclerosis.
- Associated pathologies: tympanic retraction, effects of chronic otitis, tubal dysfunction.
- Criteria about proposed treatments:
- Anesthesia contraindications
- Operative contraindication: clotting disorders, tympanum retraction and tubal dysfunction, geyser's syndrome, single ear, patient refusal.
- Criteria relative to study's explorations: Language barrier (questionnaires, tests), cognitive disorders.
- Criteria relating to previous treatment: Previous hearing aid or surgery Administrative criteria: Patients minors, incapable adults, adults under guardianship, incapable of giving consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Toulouse University Hospital (CHU de Toulouse)
Toulouse, 31059, France
Related Publications (1)
Molinier CE, Gallois Y, Deguine O, Iversenc G, Vales O, Taoui S, Lepage B, Fraysse B, Marx M. Stapedotomy Versus Hearing Aids in the Management of Conductive Hearing Loss Caused by Otosclerosis: A Prospective Comparative Study. Otol Neurotol. 2022 Aug 1;43(7):773-780. doi: 10.1097/MAO.0000000000003585.
PMID: 35878633RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mathieu MARX, MD
Toulouse University Hospital (CHU Toulouse)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 26, 2015
First Posted
May 28, 2015
Study Start
September 1, 2015
Primary Completion
December 1, 2017
Study Completion
December 1, 2017
Last Updated
December 10, 2025
Record last verified: 2018-05